For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Where to now for pharmacy?
+Columns
Where to now for pharmacy?
Thursday 5 April 2018, 01:27 PM

It’s easy to see why pharmacists want a greater role in primary care but they straddle an uneasy divide between healthcare and retail, writes Barbara Docherty
I make no secret of the fact that I love Doc Martin. Even his grumpiness can be endearing. I have competitions with myself to see if I can get the dia
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.